CHMP issues positive opinion to expand EU label for Gilenya

Gilenya, or Fingolimod, is the first approved oral disease modifying drug for MS.
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:
Contact MSUK

CHMP issues positive opinion to expand EU label for Gilenya

Post by MSUK »

CHMP issues positive opinion to expand EU label for Gilenya in RRMS

Swiss drug giant Novartis said that the Committee for Medicinal Products for Human Use or CHMP has issued a positive opinion to expand the EU label for Gilenya (fingolimod) in relapsing remitting multiple sclerosis or RRMS..... Read More - http://www.ms-uk.org/gilenya
MS-UK - http://www.ms-uk.org/
Top
Post Reply
  • Similar Topics
    Replies
    Views
    Last post

Return to “Gilenya”